(Q35045671)

6 August 2017

0 references

Severe hypersensitivity pneumonitis associated with everolimus therapy for neuroendocrine tumour: a case report (English)

1 reference

6 August 2017

author name string

Camille Sibertin-Blanc

1

1 reference

6 August 2017

Emmanuelle Norguet

2

1 reference

6 August 2017

Muriel Duluc

3

1 reference

6 August 2017

Guillaume Louis

4

1 reference

6 August 2017

Jean-François Seitz

5

1 reference

6 August 2017

Laetitia Dahan

6

1 reference

6 August 2017

publication date

18 November 2013

1 reference

6 August 2017

1 reference

6 August 2017

volume

6

1 reference

6 August 2017

page(s)

471

1 reference

Everolimus for advanced pancreatic neuroendocrine tumors.

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3843542

Pneumonitis associated with mammalian target of rapamycin inhibitors in renal transplant recipients: a single-center experience

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3843542

Noninfectious pneumonitis after everolimus therapy for advanced renal cell carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3843542

Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3843542

Characterization of pneumonitis in patients with advanced non-small cell lung cancer treated with everolimus (RAD001).

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3843542

Sirolimus and everolimus induced pneumonitis in adult renal allograft recipients: experience in a center.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3843542

Current development of mTOR inhibitors as anticancer agents

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3843542

Everolimus-associated pneumonitis in 3 heart transplant recipients

8 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-0500-6-471

Comparative analysis of adverse events requiring suspension of mTOR inhibitors: everolimus versus sirolimus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-0500-6-471

Severe everolimus-associated pneumonitis in a renal transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-0500-6-471

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-0500-6-471

21 January 2018

Identifiers

DOI

10.1186/1756-0500-6-471

1 reference

Dimensions Publication ID

6 August 2017

0 references

1 reference

6 August 2017

1 reference